Active11267746Private limited companyBirmingham

QUEST PHARM LIMITED

Significant control: Quest Legacy Limited (75–100%)

Companies HouseCompanies House

From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms

Coming soon · product and service lists

What does Quest Pharm Limited sell?

Registered activity: Manufacture of pharmaceutical preparations (SIC 21200). We’re building product and service lists for UK companies. Get this one when it’s ready.

One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01

Summary

Generated from filed data · no estimates

QUEST PHARM LIMITED is an active private limited company (company number 11267746) incorporated on 21 March 2018, registered in Birmingham. Its registered activity is manufacture of pharmaceutical preparations (SIC 21200). Latest small accounts cover the period ending 30 April 2025, showing net assets of £6.00m and cash of £6.59m, with 5 employees on average. Net assets rose 14% on the prior period (£5.24m).

Peer position · net assets

By net assets it sits in the top quarter of 307 comparable companies in the UK (median £1,000, upper quartile £146k).

02

Ownership and control

1 active · 2 other
  • Quest Legacy Limited
    corporate entity · since 26 March 2026
    • owns 75–100% of shares
    • holds 75–100% of voting rights
    • can appoint or remove directors
  • persons with significant control statement · since 21 March 2018 · ceased 7 September 2020
  • Dr Majad Hussain
    Individual · since 7 September 2020 · ceased 26 March 2026
    • owns 25–50% of shares
    • holds 25–50% of voting rights

Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.

03

Key dates

Incorporated
21 March 20188 yrs ago
Next accounts due
30 January 2027in 98 days
Confirmation statement due
4 April 2027in 162 days

Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.

04

Activity

SIC 21200
Manufacture of pharmaceutical preparations
Accounts type
Total Exemption Full
Size band
MicroCompanies Act thresholds
05

Financials

2 periods on record · latest ending 30 April 2025
Net assets
£6.00m
+14%vs Apr 2024
Cash at bank
£6.59m
+49%vs Apr 2024
Turnover
Not reported
Employees
5
No changevs Apr 2024
Net assets
£6.00m
Cash at bank
£6.59m
Average employees
5
Filed accounts by period, newest first
Period endNet assetsCashDebtorsCreditors <1yTurnoverProfitEmployees
30 April 2025£6.00m£6.59m£701k———5
30 April 2024£5.24m£4.42m£1.69m———5
Cash per employee£1.32mCash ÷ average employees

Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.

06

Filing and accounts signals

Facts from the register · no rating
  • Net assets above zeroNet assets £5,995,868 at 30 April 2025
  • Net assets up 10% or more on the prior period+14.4% vs prior period
  • Cash at bank of £50,000 or moreCash £6,593,664
  • Incorporated five or more years agoIncorporated 21 March 2018

Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.

07

Timeline

Newest first
  1. Confirmation statement duein 162 days
  2. Next accounts duein 98 days
  3. Accounts period endNet assets £6.00m · small accounts
  4. Accounts period endNet assets £5.24m · small accounts
  5. Incorporated
08

Similar companies in Birmingham

Same activity (manufacture of pharmaceutical preparations), closest in incorporation date
09

Reminders for QUEST PHARM LIMITED

Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.

Source: Companies House register, snapshot 2026-08-31; accounts from the Companies House accounts data product. Open Government Licence v3.0. View on Companies House. Methodology · About · Markdown.